Dr. Chandrakanth M V

Dr Chandrakanth M V is a Senior Consultant and Academic Head in Medical Oncology and Haemato-Oncology in Kolkata with 17 years of experience in the management of solid tumours, haematological malignancies, immunotherapy, chemotherapy, and stem cell transplantation.

He holds a DM in Medical Oncology from Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai with a Gold Medal for highest academic performance, a Fellowship in Haemato-Oncology from Tata Memorial Hospital, an MRCP (SCE) from the Royal College of Physicians, UK (2020), and an ECMO from the European Society for Medical Oncology.

Patients seeking expert cancer treatment in Kolkata, trusted breast cancer treatment in Kolkata, or advanced immunotherapy and targeted therapy in Kolkata will find Dr Chandrakanth at NH Rabindranath Tagore International Institute of Cardiac Sciences, Mukundapur and Narayana Superspeciality Hospital, Shibpur.

He is the founder of Bengal Cancer Support Group, the founder of MV Onco, an oncology education platform, and has received the Torrent Young Scholar National Award 2016 and nine Gold Medals in MBBS from Rajiv Gandhi University of Health Sciences, Karnataka.

He also received the Best Oral Presentation Award at the Indian Cancer Congress 2023 and the Best Oral Presentation Award at DALOS Conference 2021.

He consults in English, Hindi, Bengali, Kannada, and Marathi, ensuring clear communication for patients from across India.

Specialty Areas and Treatments

Dr Chandrakanth M V delivers comprehensive medical oncology, haemato-oncology, and palliative care through evidence-based, precision-guided, and patient-centred treatment approaches with a special clinical focus on breast, gastrointestinal, and genitourinary cancers.

Treatment Modalities

Dr Chandrakanth offers the full spectrum of systemic cancer treatment approaches:

• Immunotherapy checkpoint inhibitors including PD-1, PD-L1 directed agents
• Chemotherapy intravenous, oral, intrathecal, and metronomic
• Targeted Therapy and Precision Medicine for molecularly profiled cancers
• Stem Cell Transplantation for haematological malignancies
• HIPEC (Hyperthermic Intraperitoneal Chemotherapy) for peritoneal malignancies
• PIPAC Treatment for advanced peritoneal surface malignancies
• Antibody Drug Conjugates (ADCs) including T-DM1 and T-DXd for advanced solid tumours
• Hormone Therapy CDK 4/6 inhibitors, aromatase inhibitors, and endocrine agents
• Palliative and Supportive Care with certified expertise (CCEPC, Indian Academy of Palliative Care)

Breast Cancer in Kolkata

Dr Chandrakanth has deep expertise in breast cancer management with active engagement in cutting-edge HER2-directed therapy trials including DESTINY-Breast studies:

• HER2 Positive Breast Cancer trastuzumab, pertuzumab, T-DM1, T-DXd regimens
• Triple Negative Breast Cancer chemotherapy and immunotherapy
• Hormone Receptor Positive Breast Cancer CDK 4/6 inhibitors and endocrine therapy
• Metastatic Breast Cancer systemic management including ADC-based regimens
• Neoadjuvant and Adjuvant Breast Cancer chemotherapy protocols
• Post-Neoadjuvant Escalation T-DM1 and T-DXd for residual HER2-positive disease

Gastrointestinal and Hepatobiliary Cancers in Kolkata

Dr Chandrakanth has published research on head and neck and upper GI cancer systemic management:

• Oesophageal Cancer nivolumab-based regimens including CheckMate 648 and 577 protocols
• Gastric and Gastroesophageal Junction Cancer nivolumab CheckMate 649 protocol
• Colorectal Cancer FOLFOX, FOLFIRI, bevacizumab, cetuximab
• Pancreatic Cancer gemcitabine-based systemic management
• Hepatocellular Carcinoma sorafenib and immunotherapy
• Gallbladder and Cholangiocarcinoma platinum-based regimens

Head and Neck Cancer in Kolkata

Dr Chandrakanth has published research on systemic treatment outcomes in recurrent and metastatic head and neck squamous cell carcinoma:

• Recurrent and Metastatic SCCHN PCC regimen followed by nivolumab with published outcomes
• HPV Negative Oropharyngeal Cancer TORS and systemic therapy coordination
• Nasopharyngeal Carcinoma chemotherapy and immunotherapy
• Laryngeal Cancer organ preservation protocols

Lung Cancer in Kolkata

• EGFR, ALK, ROS1 Mutated NSCLC targeted therapy
• Immunotherapy for Lung Cancer PD-L1 directed agents
• Small Cell Lung Cancer chemotherapy and immunotherapy

Genitourinary Cancers in Kolkata

• Kidney Cancer (Renal Cell Carcinoma) targeted therapy and immunotherapy
• Prostate Cancer hormone therapy and chemotherapy
• Bladder and Urothelial Cancer chemotherapy and immunotherapy
• Testicular Cancer BEP and salvage regimens

Haematological Malignancies in Kolkata

Dr Chandrakanth trained at Tata Memorial Hospital with dedicated Fellowship in Haemato-Oncology and manages the full spectrum of blood cancers:

• Hodgkin and Non-Hodgkin Lymphoma standard and novel regimens
• Acute and Chronic Leukaemia induction and consolidation chemotherapy
• Multiple Myeloma proteasome inhibitors and immunomodulatory agents
• Stem Cell Transplantation for eligible haematological malignancy patients

Palliative and Supportive Oncology Care in Kolkata

Dr Chandrakanth holds the CCEPC certification from the Indian Academy of Palliative Care (2021), a rare distinction among medical oncologists, enabling specialist-led palliative and supportive care integration:

• Cancer Pain Management specialist protocols
• Symptom Management during active cancer treatment
• Hospice and End-of-Life Care Planning
• Supportive Care Integration from diagnosis through treatment

Qualifications and Credentials

• MBBS from MVJ Medical College, Bengaluru, Rajiv Gandhi University of Health Sciences (2009), with Nine Gold Medals and Best Outgoing Student Award
• MD Internal Medicine from SCB Medical College, Cuttack (2012)
• Fellowship in Haemato-Oncology, Tata Memorial Hospital, Mumbai (2013)
• DM Medical Oncology from Homi Bhabha National Institute, Mumbai (2016), with Gold Medal for highest academic performance
• DNB Medical Oncology from National Board of Examinations, New Delhi (2017)
• ECMO (European Certification in Medical Oncology), European Society for Medical Oncology (2017)
• MRCP (SCE), Royal College of Physicians, UK (2020)
• CCEPC, Indian Academy of Palliative Care (2021)

Dr Chandrakanth holds active medical council registration with the West Bengal Medical Council (Reg. No. 80331, 2019), supporting his current practice as a medical oncologist in Kolkata.

His ECMO from the European Society for Medical Oncology (2017) reflects adherence to internationally benchmarked oncology practice standards.

Awards and Recognitions

• Nine Gold Medals and Best Outgoing Student Award, MBBS, Rajiv Gandhi University of Health Sciences, Karnataka
• Gold Medal for Highest Score and Best Academic Performance, DM Medical Oncology, Tata Memorial Hospital, Mumbai
• Torrent Young Scholar National Award, 2016
• Best Oral Presentation, Indian Cancer Congress, July 2023
• Best Oral Presentation, DALOS Conference, December 2021
• Best Oral Presentation, Women Cancer Initiative Conference, October 2015
• Best Poster Presentation, Mumbai Haematocon, 2013
• Best Poster Presentation, APICON, 2012
• Best Orator Award, Pediatrics CME, MVJ Medical College, Bangalore, 2008
• Winner, National Level Quiz Competition, Indian Academy of Pediatrics, 2008

Milestones and Clinical Achievements

• Academic Head, Narayana Health Kolkata, leading oncology education and clinical training for postgraduate trainees
• Founder, Bengal Cancer Support Group, supporting cancer awareness and patient care across West Bengal
• Founder, MV Onco, a digital oncology education platform simplifying complex cancer science for clinicians and trainees, with over 2,700 LinkedIn followers engaging with his content
• Principal Investigator and Co-Investigator in global clinical trials at Narayana Health, Kolkata
• Mentor for DNB trainees in Medical Oncology at Narayana Health
• Organizing Secretary, ICON Conference 2019, Kolkata, one of India's major oncology academic conferences
• Executive Committee Member, ISMPO, contributing to national medical oncology policy and education
• Trained for nearly five years at Tata Memorial Hospital, Mumbai, progressing from Fellow to Special Registrar in Medical Oncology
• Active contributor to oncology education through LinkedIn MV Onco posts covering DESTINY-Breast trials, nivolumab in upper GI cancers, Kaplan-Meier interpretation, and real-world oncology evidence

Research and Publications

Dr Chandrakanth has published peer-reviewed research in indexed national and international oncology journals and contributed to multi-centre collaborative studies. Selected publications from source documents include:

• Weekly Paclitaxel, Carboplatin and Cetuximab (PCC) Combination Followed by Nivolumab in Platinum-Sensitive Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck: A Retrospective Analysis from Two Institutions in India, F1000Research, March 2025
• Weekly Paclitaxel, Carboplatin and Cetuximab (PCC) Combination Followed by Nivolumab in Platinum-Sensitive Recurrent and Metastatic SCCHN, Annals of Oncology, November 2020 (Poster Presentation)
• Compliance to Therapy as a Prognostic Marker in Osteosarcoma: New Kid on the Block, Diagnostic Pathology Open Access, 2016, 1: 119
• Dengue Fever as a Cause, PubMed indexed journal (reference available)

His Narayana Health blog contributions include:

• Vaping vs Smoking: What the Young Need to Know About Cancer Risk, Narayana Health Blog, November 2024
• The Role of Family History in Cancer Risk, Narayana Health Blog

Professional Memberships

• Member, Royal College of Physicians, UK (MRCP)
• Member, European Society for Medical Oncology (ESMO)
• Member, Indian Academy of Palliative Care (IAPC)
• Executive Committee Member, Indian Society of Medical and Paediatric Oncology (ISMPO)
• Founder Member, Asian Cardio Oncology Society (ACOS)
• Member, American Society of Clinical Oncology (ASCO)
• Member, Indian Society of Oncology (ISO)
• Organizing Secretary, ICON Conference 2019, Kolkata

Hospital Affiliations in Kolkata

Current Practice

• NH Rabindranath Tagore International Institute of Cardiac Sciences, Mukundapur, Kolkata as Senior Consultant and Academic Head — Consultation Fee: ₹1350
• Narayana Superspeciality Hospital, Shibpur, Kolkata as Consultant — Consultation Fee: ₹1350

Past Experience

• Tata Memorial Hospital, Mumbai as Special Registrar, Medical Oncology (February 2016 to February 2017), Senior Resident, Medical Oncology (July 2013 to July 2016), and Fellow, Haemato-Oncology (June 2012 to June 2013)
• SCB Medical College, Cuttack as Junior Resident, Medicine (May 2009 to May 2012)
• Narayana Multispeciality Hospital, Andul Road, Kolkata as Consultant

Book an Appointment with Dr Chandrakanth M V, Medical Oncologist in Kolkata

To check consultation fees and book a priority appointment with Dr Chandrakanth M V at NH Rabindranath Tagore International Institute of Cardiac Sciences, Mukundapur or Narayana Superspeciality Hospital, Shibpur, Kolkata, visit HexaHealth for a smooth and hassle-free booking experience.